Christine M. Cotter

Statistics

Publications

Citations

401

H-Index

Active since

2017

Affiliations

University of North Carolina at Chapel Hill(Current)

Duke Medical Center

Baylor College of Medicine

University of Michigan

Johns Hopkins University

Christine M. Cotter is an author at University of North Carolina at Chapel Hill specializing in medicine, oncology, and metastatic breast cancer treatment.

Publications per year

2017–2019

Publications

TBCRC 022: A Phase II Trial of Neratinib and Capecitabine for Patients With Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer and Brain Metastases

Rachel A. Freedman, Rebecca Gelman, Carey K. Anders et al. · Journal of Clinical Oncology · 2019 · 338 citations · Full text

Medicine, Oncology, Pharmacology +17

TBCRC 022: Phase II trial of neratinib + capecitabine for patients (Pts) with human epidermal growth factor receptor 2 (HER2+) breast cancer brain metastases (BCBM).

Rachel A. Freedman, Rebecca Gelman, Michelle Melisko et al. · Journal of Clinical Oncology · 2017 · 36 citations

Medicine, Oncology, Pharmacology +17

Pre- and Postoperative Neratinib for HER2-Positive Breast Cancer Brain Metastases: Translational Breast Cancer Research Consortium 022

Rachel A. Freedman, Rebecca Gelman, Nathalie Y.R. Agar et al. · Clinical Breast Cancer · 2019 · 27 citations · Full text

Medicine, Oncology, Surgery +14

1–3 of 3